Infecciones COVID-19 posterior a vacunación en la Zona Norte del Ecuador
DOI:
https://doi.org/10.18537/mskn.14.01.06Keywords:
pandemia, COVID-19, infecciones nuevas, vacunación, EcuadorAbstract
This study aimed to characterization of COVID-19 infections after vaccination in the northern part of Ecuador. Epidemiological, descriptive, quantitative and longitudinal study. A structured online self-fill survey validated by experts was applied to a sample of 1,541 people vaccinated with the first and second doses against COVID-19. The characterization variables used were age by life cycle, ethnicity, new COVID-19 infections, and disease severity. The incidence of COVID-19 after vaccination was 17.20% in men and 20.67% in women; mainly in the life cycle of 20 to 39 years and after the second dose of vaccination. In all cases the severity was mild without requiring hospitalization. It was concluded that the cases of infection after COVID-19 vaccination turned out to be of low incidence and severity, with a favorable correlation to the number of doses received.
Keywords: pandemic, COVID-19, new infections, vaccination
Downloads
Metrics
References
Bagshaw, S. M., Zuege, D. J., Stelfox, H. T., Opgenorth, D., Wasylak, T., Fraser, N. y Nguyen, T. X. (2022). Association between pandemic coronavirus disease 2019 public health measures and reduction in critical care utilization across
ICUs in Alberta, Canada. Critical Care Medicine, 50(3), 353–362. https://doi.org/10.1097/CCM.0000000000005275
Bedoya-Sommerkamp, M., Medina-Ranilla, J., Chau-Rodríguez, V., Li-Soldevilla, R., Vera-Albújar, Á. y García, P. (2021). Variantes del SARS-CoV-2: epidemiología, fisiopatología y la importancia de las vacunas. Revista Peruana de Medicina Experimental y Salud Publica, 38(3), 442-451. https://dx.doi.org/10.17843/rpmesp.2021.383.8734
Bruno, M., Armen, S., García-Fontana, B. y Pereira-Prado, V. (2022). Fisiopatología de la enfermedad COVID-19. Odontoestomatología, 24(39), e312. https://doi.org/10.22592/ode2022n39e312
Cairol, A., Morún, W., Loaiza, L., Segura, E., Arguedas, E., y González, S. (2022). Estudio de Cohorte del impacto y eficacia del proceso de vacunación contra la COVID-19 en la población inmunizada en Costa Rica durante el 2021. Revista De La Facultad De Medicina De La Universidad De lberoamérica, 1(1). https://doi.org/10.54376/rcmui.v4i2.101
Center for Systems Science and Engineering (CSSE) at Johns Hopkins University; (2022). https://coronavirus.jhu.edu/map.html
Chaparro, N., Samper, D. y Franco, A. (2021). COVID-19 vaccine safety. Revista Peruana de Medicina Experimental Salud Pública, 38(4), 634–42. https://doi.org/10.17843/rpmesp.2021.384.9308
Corey, L., Mascola, J., Fauci, A. y Collins, F. (2020). A strategic approach to COVID-19 vaccine RyD. Science (New York, N.Y.), 368(6494), 948–950. https://doi.org/10.1126/science.abc5312
Cruz, E., Galindo, B. y Toledo, G. (2019). Vigilancia de los eventos adversos atribuidos a la inmunización. Revista Cubana de Higiene y Epidemiología, 56(1). https://revepidemiologia.sld.cu/index.php/hie/article/view/207/267
Gómez, J., Álvarez, M. y Martín, S. (2021). Efectividad y seguridad de las vacunas para el SARS-CoV-2 actualmente disponibles. Formación médica continuada en atención primaria, 28(8), 442–451. https://doi.org/10.1016/j.fmc.2021.07.001
González-Castro, A., Cuenca-Fito, E., Fernandez, A., Ferrero-Franco, R., Rodríguez-Borregán, J. y Gonzalez, C. (2022). Impacto de la vacunación en los ingresos en una unidad de cuidados intensivos por COVID-19 en un hospital de tercer nivel. Medicina intensiva, 46(7), 406–407. https://doi.org/10.1016/j.medin.2021.08.002
Guanche-Garcell, H. y Barbán-Arias, R. (2021). Reinfección, inmunidad y prevención de la transmisión en la COVID-19. Revista Habanera de Ciencias Médicas, 20(4), e4101. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2021000400015&lng=es&tlng=es.
Hanna, P., Issa, A., Noujeim, Z., Hleyhel, M. y Saleh, N. (2022). Assessment of COVID-19 vaccines acceptance in the Lebanese population: a national cross-sectional study. Journal of pharmaceutical policy and practice, 15(1), 5. https://doi.org/10.1186/s40545-021-00403-x
Kantarcioglu, B., Iqbal, O., Lewis, J., Carter, C., Singh, M., Lievano, F., Ligocki, M., Jeske, W., Adiguzel, C., Gerotziafas, G. y Fareed, J. (2022). An update on the status of vaccine development for SARS-CoV-2 including variants. Official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 28, 10760296211056648. https://doi.org/10.1177/10760296211056648
López-Matiacci, M., Caso-Colón, M., Albañil-Ballesteros, M., Olivas-Domínguez, A. y García-Martínez, J. (2021). Reinfección COVID-19 precoz. Pediatría Atención Primaria, 23(92), e157-e161. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1139-76322021000400017&lng=es&tlng=pt.
Lozada-Requena, I. y Núñez-Ponce, C. (2020). COVID-19: respuesta inmune y perspectivas terapéuticas. Revista Peruana de Medicina Experimental y Salud Publica, 37(2), 312-319. https://dx.doi.org/10.17843/rpmesp.2020.372.5490
Luzuriaga, J., Marsico, F., García, E., González, V., Kreplak, N., Pifano, M. y González, S. (2021). Impact of vaccines against COVID-19 on the incidence of new SARS-COV2 infections in health care workers of the Province of Buenos Aires. In SciELO Preprints. https://doi.org/10.1590/SciELOPreprints.2068
Mojica-Crespo, R. y Morales-Crespo, M. (2020). Pandemia COVID-19, la nueva emergencia sanitaria de preocupación internacional: una revision. Semergen, 46 Suppl 1, 65–77. https://doi.org/10.1016/j.semerg.2020.05.010
Montaño-Armendáriz, N., Zamudio-Cuevas, Y., Fernández-Torres, J., Martínez-Flores, K. y Luján-Juárez, I. (2022). Importancia de la autoinmunidad inducida por SARS-CoV-2 y desarrollo de enfermedades autoinmunes post-vacunación. Revista Alergia México, 69(2), 78-88. https://doi.org/10.29262/ram.v69i2.1153
Ortiz de Lejarazu L. (2021). Futuro de la vacunación frente a la infección por SARS-CoV-2. Open Respiratory Archives, 3(3), 100117. https://doi.org/10.1016/j.opresp.2021.100117
Pereira-Rodriguez, J., Waiss, S., Velásquez, X., López, O. y Quintero, J. (2020). Physiotherapy and its challenge against Covid-19: physiotherapy and Covid-19. In SciELO Preprints. https://doi.org/10.1590/SciELOPreprints.157
Plasencia-Urizarri, T., Aguilera-Rodríguez, R. y Almaguer-Mederos, L. (2020). Comorbilidades y gravedad clínica de la COVID-19: revisión sistemática y meta-análisis. Revista Habanera de Ciencias Médicas, 19(Supl. 1), e3389. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2020000400002&lng=es&tlng=es.
Rodríguez-Morales, A., Cardona-Ospina, J. y Villamil-Gómez, W. (2021). ¿Deberíamos preocuparnos por la reinfección en COVID-19?. Infection, 25(2), 77-78. https://doi.org/10.22354/in.v25i2.922
Rodríguez-Hernández, C. y Sanz-Moreno, L. (2020). Inmunidad frente a SARS-CoV-2: caminando hacia la vacunación. Revista Española de Quimioterapia, 33(6), 392–398. https://doi.org/10.37201/req/086.2020
Ruiz-Bravo, A. y Jiménez-Valera, M. (2020). SARS-CoV-2 y pandemia de síndrome respiratorio agudo (COVID-19). Ars Pharmaceutica, 61(2), 63-79. https://dx.doi.org/10.30827/ars.v61i2.15177
Ruiz-Cantero, M. (2021). Las estadísticas sanitarias y la invisibilidad por sexo y de género durante la epidemia de COVID-19. Gac Sanit, 35(1): 95-98. https://dx.doi.org/10.1016/j.gaceta.2020.04.008
Rutkowski, K., Mirakian, R., Till, S., Rutkowski, R. y Wagner, A. (2021). Adverse reactions to COVID-19 vaccines: A practical approach. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology, 51(6), 770–777. https://doi.org/10.1111/cea.13880
Sierra-Moros, M., Martínez-Sánchez, E., Monge-Corella, S., García, L., Suárez-Rodríguez, B. y Simón Soria, F. (2022). Lecciones de la vigilancia de la COVID-19. Necesidad urgente de una nueva vigilancia en salud pública. Gaceta sanitaria, 36 Suppl 1, S68–S75. https://doi.org/10.1016/j.gaceta.2022.03.001
Tang, X., Wu, C., Li, X., Song, Y., Yao, X., Wu, X., Duan, Y., Zhang, H., Wang, Y., Qian, Z., Cui, J. y Lu, J. (2020). On the origin and continuing evolution of SARS-CoV-2. National science review, 7(6), 1012–1023. https://doi.org/10.1093/nsr/nwaa036
Tregoning, J., Flight, K., Higham, S., Wang, Z. y Pierce, B. (2021). Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nature reviews. Immunology, 21(10), 626–636. https://doi.org/10.1038/s41577-021-00592-1
Urbiztondo, L., Borràs, E. y Mirada, G. (2020). Vacunas contra el coronavirus. Vacunas, 21(1), 69–72. https://doi.org/10.1016/j.vacun.2020.04.002
Vázquez, J., Menchén, D., Lloréns, M. y Moreno, J. (2022). Manifestaciones sistémicas y extrapulmonares en la COVID-19. Medicine, 13(55), 3235–3245. https://doi.org/10.1016/j.med.2022.05.004
Vicente-Herrero, M. y Rueda-Garrido, J. (2020). Criterios de vulnerabilidad frente a infección Covid-19 en trabajadores. Revista de la Asociación Española de Especialistas en Medicina del Trabajo, 29(2), 12-22. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1132-62552020000200004&lng=es&tlng=es.
World Health Organization (2022). COVID-19 Weekly Epidemiological Update. Global overview, 107(31). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Wu, Z. y McGoogan, J. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19). JAMA, 323(13), 1239–1242. https://doi.org/10.1001/jama.2020.2648
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Yu Ling Reascos-Paredes, Silvia Lorena Acosta-Balseca, Widmark Enrique Báez-Morales, Juan Carlos Vásquez-Cazar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright © Autors. Creative Commons Attribution 4.0 License. for any article submitted from 6 June 2017 onwards. For manuscripts submitted before, the CC BY 3.0 License was used.
You are free to:
 |
Share — copy and redistribute the material in any medium or format |
 |
Adapt — remix, transform, and build upon the material for any purpose, even commercially. |
Under the following conditions:
 |
Attribution — You must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licenser endorses you or your use. |
| No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the licence permits. |
